Impact Biomedical (IBO) Assets Average (2023 - 2026)

Impact Biomedical's Assets Average history runs 4 years deep, the most recent figure standing at $17.2 million for Q1 2026.

• Quarterly Assets Average fell 14.5% year-over-year to $17.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.2 million (down 14.5% YoY) and the FY2025 annual result came in at $18.8 million, down 41.94% from the prior year.
• Assets Average was $17.2 million for Q1 2026 at Impact Biomedical, down from $17.8 million in the prior quarter.
• Across five years, Assets Average topped out at $45.5 million in Q3 2023 and bottomed at $17.2 million in Q1 2026.
• A 4-year average of $31.9 million and a median of $33.5 million in 2024 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2024 — Assets Average slipped 0.29% — and 2025, when it slumped 58.96%.
• Impact Biomedical's Assets Average stood at $44.9 million in 2023, then dropped by 25.34% to $33.5 million in 2024, then slumped by 46.83% to $17.8 million in 2025, then fell by 3.15% to $17.2 million in 2026.
• Business Quant data shows IBO's Assets Average at $17.2 million in Q1 2026, $17.8 million in Q4 2025, and $18.6 million in Q3 2025.